Import Alert 54-10 lets FDA detain herbal supplements and bulk botanicals without examining them when they are labeled as containing Aristolochia or related plants. Aristolochic acid causes kidney failure and cancer. Release needs LC-MS lab evidence that the product is free of it.
Listed on 54-10? Send us the product, botanical ingredients and shipment details. We plan the testing and the request.
Get a 54-10 Case Review| Item | Import Alert 54-10 |
|---|---|
| Official title | DWPE of Bulk/Finished Dietary Supplement Products Containing Aristolochic Acid |
| Botanicals | Aristolochia spp. and certain Asarum, Cocculus and Thottea spp. |
| Food charges | 402(f)(1)(A), 402(f)(1)(D), 402(a)(1) |
| Drug charges | Unapproved new drug 505(a); misbranded 502(f)(1) |
| Release | LC-MS evidence the product is free of aristolochic acid |
| Removal contact | Division of Import Operations, (301) 796-0356 |
Details follow the current text of Import Alert 54-10, published December 10, 2020.
Any Aristolochia species, as a supplement or ingredient.
Listed Asarum species, including the one Red List entry.
Listed species of both genera.
Traditional formulas known to contain aristolochic acid.
Roots, powders and extracts.
Capsules, tablets, teas and pills.
Analytical evidence that the product is free of aristolochic acid. FDA says only certificates of analysis or other documents that rely on liquid chromatography-mass spectrometry (LC-MS) should be accepted to release detained product.
The alert directs all requests for removal from DWPE to FDA's Division of Import Operations at (301) 796-0356. Expect FDA to want LC-MS results and proof of correct botanical identification.
Need samples pulled and tested for a detained supplement shipment? Our sister company, FDA Detention Sampling, coordinates sample collection, chain of custody and testing with LAAF-accredited laboratories nationwide. Call +1 (786) 561-3726.
FDA's framework is in RPM Chapter 9-8; FDA removal guidance explains what a request should include.
Removal help for food and supplements.
Supplement registration and labeling.
Supplements with hidden drugs.
Germanium supplements.
Heavy metals in herbal products.
Check claims and ingredient labeling.
We review the botanicals, plan LC-MS testing and prepare the request to FDA. We are an independent compliance firm, not FDA or a law firm, and no one can guarantee FDA's decision.
Contact our specialists, email info@fdaregistrationassistance.com, or call +1 (928) 275-8333. Import alert removal · Supplement services · Contact.
Get a 54-10 Case ReviewFDA Registration Assistance is a private consulting firm, not FDA or any government agency. FDA registration is not FDA approval, clearance or certification.
Import Alert 54-10 is titled "Detention Without Physical Examination of Bulk/Finished Dietary Supplements Products Containing Aristolochic Acid." It lets FDA detain products labeled as containing certain botanicals without examining each shipment.
A substance found in plants of the Aristolochiaceae family. FDA describes it as a potent carcinogen and nephrotoxin that causes kidney damage and can cause or contribute to kidney failure. Small amounts taken for years can cause serious, irreversible effects.
Any Aristolochia species, plus listed species of Asarum, Cocculus and Thottea, as bulk or finished dietary supplements, drugs or other products, and products from firms named in the alert.
FDA gives two ways: the plant on the label was misidentified, or it was confused with an aristolochia-containing plant because traditional Chinese names were misread or are similar.
The alert lists formulas including Dang Gui Si Ni, Du Hou Ji Sheng Tang, Xiao Qing Long Tang, Chuan Xiong Cha Tiao Wan, Da Qin Jiao Tang, Ma Huang Fu Zi Xi Xin Tang, San Bi Tang, Jiu Wei Qiang Hou Tang and Qing Shang Juan Tong Tang.
For supplements: adulteration under sections 402(f)(1)(A) (significant or unreasonable risk), 402(f)(1)(D) and 402(a)(1) (poisonous or deleterious substance). If the labeling makes disease claims, the product is charged as an unapproved new drug under section 505(a) and a misbranded drug under section 502(f)(1). Refusal is under section 801(a)(3).
The alert currently shows one firm, Kaiser Pharmaceutical Co. in Taiwan, for Xi Xin (an Asarum product). Check Import Alert 54-10 for the current list.
When the firm provides analytical evidence that the product is free of aristolochic acid. FDA says only certificates of analysis or other documents based on liquid chromatography-mass spectrometry (LC-MS) should be accepted as a basis for release.
LC-MS can identify and measure aristolochic acid specifically. FDA does not accept results from less specific methods to release detained product under this alert.
The alert says all requests for removal from DWPE should be addressed to FDA's Division of Import Operations, at (301) 796-0356. Expect to show LC-MS results and correct botanical identification.
Not necessarily. Products with listed botanicals should be evaluated to show they are free of aristolochic acid. Correct species identification and LC-MS results are what FDA looks at.
The alert lists the Division of Import Operations at (301) 796-0356 for removal requests, and the Office of Regulatory Science at (301) 796-6600 for sampling and analytical methods.
The alert covers bulk and finished products of any type that contain the listed botanicals. The one Red List entry is classed as herbals and botanicals, not teas, but teas containing these plants can still be detained.
Importers must keep a Foreign Supplier Verification Program that covers aristolochic acid and botanical misidentification where it is a known or reasonably foreseeable hazard, with supplier verification and testing for higher-risk products. See our FSVP service.
No. FDA makes every removal decision. We are an independent compliance firm, not FDA or a law firm. We help you build a complete, well-documented request.
Tell us what your company makes, sells, or distributes, where each product is manufactured or packed, your U.S. importer or buyer arrangement, label readiness, and target shipment date.
Submitting this inquiry does not purchase a service or authorize paid work. Our team can discuss the scope and required materials before you commission assistance. Fields marked with an asterisk are required.